Why the study?
Does sirolimus-eluting stenting after rotational atherectomy reduce major adverse cardiac events in patients with hard coronary lesions compared to bare-metal stenting?
Does sirolimus-eluting stenting after rotational atherectomy reduce major adverse cardiac events in patients with hard coronary lesions compared to bare-metal stenting?
Sirolimus-eluting stenting after rotational atherectomy reduces target lesion revascularization and MACE compared to bare-metal stenting in hard coronary lesions, though this benefit is attenuated in dialysis patients.
No takes yet. Share an insight, caveat, or question.
May support SES over BMS after ROTA to lower MACE in hard lesions; leaves open randomized confirmation.
Tamekiyo et al. (2009) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: